Market Closed -
Singapore S.E.
10:07:41 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.465
SGD
|
-1.06%
|
|
-1.06%
|
-7.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
2,697
|
2,720
|
2,720
|
2,696
|
2,813
|
2,616
|
Enterprise Value (EV)
1 |
4,339
|
4,300
|
3,716
|
2,696
|
5,047
|
4,967
|
P/E ratio
|
65.9
x
|
-79
x
|
-21.1
x
|
96.3
x
|
27.9
x
|
27.8
x
|
Yield
|
6.89%
|
6.83%
|
6.94%
|
7.07%
|
12.4%
|
8.6%
|
Capitalization / Revenue
|
1.72
x
|
1.75
x
|
1.73
x
|
1.34
x
|
1.38
x
|
1.27
x
|
EV / Revenue
|
2.77
x
|
2.77
x
|
2.36
x
|
1.34
x
|
2.48
x
|
2.41
x
|
EV / EBITDA
|
15.1
x
|
14.7
x
|
11.7
x
|
6.71
x
|
11.3
x
|
12.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.04
x
|
2.38
x
|
2.44
x
|
2.8
x
|
3.23
x
|
2.92
x
|
Nbr of stocks (in thousands)
|
4,994,391
|
4,990,438
|
4,991,263
|
4,991,790
|
5,625,786
|
5,626,719
|
Reference price
2 |
0.5400
|
0.5450
|
0.5450
|
0.5400
|
0.5000
|
0.4650
|
Announcement Date
|
20/01/20
|
27/01/21
|
26/01/22
|
30/01/23
|
30/01/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
1,567
|
1,552
|
1,575
|
2,006
|
2,036
|
2,064
|
EBITDA
1 |
286.7
|
291.6
|
317.6
|
402
|
447.6
|
404
|
EBIT
1 |
113.7
|
113.4
|
140.6
|
245.3
|
242.5
|
190
|
Operating Margin
|
7.25%
|
7.31%
|
8.93%
|
12.23%
|
11.91%
|
9.21%
|
Earnings before Tax (EBT)
1 |
16.83
|
-31.27
|
39.76
|
-
|
112.8
|
116
|
Net income
1 |
38.58
|
-34.35
|
-125.9
|
28.02
|
123.9
|
94.1
|
Net margin
|
2.46%
|
-2.21%
|
-7.99%
|
1.4%
|
6.09%
|
4.56%
|
EPS
2 |
0.008200
|
-0.006900
|
-0.0258
|
0.005610
|
0.0179
|
0.0167
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0372
|
0.0372
|
0.0378
|
0.0382
|
0.0619
|
0.0400
|
Announcement Date
|
20/01/20
|
27/01/21
|
26/01/22
|
30/01/23
|
30/01/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
1,642
|
1,580
|
996
|
-
|
2,234
|
2,351
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.725
x
|
5.42
x
|
3.136
x
|
-
|
4.992
x
|
5.819
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
3.25%
|
3.88%
|
3.9%
|
1.71%
|
8.17%
|
9.8%
|
ROA (Net income/ Total Assets)
|
0.88%
|
1.2%
|
1.3%
|
-
|
2.14%
|
1.7%
|
Assets
1 |
4,404
|
-2,874
|
-9,666
|
-
|
5,782
|
5,535
|
Book Value Per Share
2 |
0.2700
|
0.2300
|
0.2200
|
0.1900
|
0.1600
|
0.1600
|
Cash Flow per Share
2 |
0.0700
|
0.0700
|
0.0500
|
0.0600
|
0.0500
|
0.0400
|
Capex
1 |
33.4
|
29
|
275
|
-
|
54.8
|
25
|
Capex / Sales
|
2.13%
|
1.87%
|
17.46%
|
-
|
2.69%
|
1.21%
|
Announcement Date
|
20/01/20
|
27/01/21
|
26/01/22
|
30/01/23
|
30/01/24
|
-
|
Last Close Price
0.465
SGD Average target price
0.57
SGD Spread / Average Target +22.58% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.00% | 1.94B | | +1.22% | 78.18B | | +0.96% | 32.47B | | +8.75% | 18.01B | | -9.28% | 11.74B | | +8.55% | 11.47B | | -2.33% | 10.43B | | +5.97% | 9.98B | | +3.48% | 9.12B | | +4.24% | 8.38B |
Diversified Chemicals
|